× Industry Reports Services Press Release Contact us About us

Brazil Oncology Market size to reach $16.5 Bn by 2027

 Request a sample

Brazil Oncology Market size is anticipated to cross USD 16.5 billion by 2027, according to a latest forecast report by Graphical Research.

Cancer is identified as one of the most prominent diseases in Brazil. It is also ranked among the top three causes of death in the country. Given such high prevalence rates, the domestic government as well as global health-related organizations operating in the country, take several measures to spread awareness regarding cancer. For instance, Brazil has implemented a non-communicable disease (NCDs) plan, running from 2011 to 2022, including cancer. The aim of NCDs plan is to address the inequalities relating to access of care. Further, initiatives such as Brazilian National Program for Control of Cervical Cancer have significantly contributed towards spreading awareness regarding cervical cancer. Strategic efforts from the World Health Organization are also noted to curb the occurrence of cancer in the country, thereby fueling the market growth. However, challenges such as uneven distribution of healthcare infrastructure persists in the country leading to a non-uniform healthcare structure. Several specialists, including cancer specialists are noted to operate in larger cities and tertiary care centers. Such uneven distribution limits the services available in remote areas, thereby causing hurdles in the market growth.

On the basis of diagnostic & treatment, the Brazil oncology market is segmented into diagnostic and treatment. The diagnostic segment is further segmented into tumor biomarkers test, imaging, biopsy, liquid biopsy, immunohistochemistry and in situ hybridization. The treatment segment is further segmented into chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others. The treatment segment was noted to account for over USD 3.4 billion in 2020. With a high prevalence of cancer in the country, different treatment options are available within the country and a stable segmental demand is anticipated throughout the forecast period.

Browse detailed statistical insights from the report, “Brazil Oncology Market Forecast 2027 By Cancer Type (Lung Cancer, Prostate Cancer, Colon & Rectal Cancer, Gastric Cancer, Esophageal Cancer, Liver Cancer, Breast Cancer), By Cancer Diagnostics & Treatment (Cancer Diagnostics {Tumor Biomarkers Tests, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization}, Cancer Treatment {Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy}), By End-use (Public {Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics}, Private {Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics}), Research Report, COVID-19 Impact Statistics, Country Outlook, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @

https://www.graphicalresearch.com/industry-insights/1836/brazil-oncology-market

On the basis of cancer type, the Brazil oncology market is segmented into lung cancer, prostate cancer, colon & rectal cancer, gastric cancer, esophageal cancer, liver cancer, breast cancer and others. The lung cancer segment is anticipated to witness a high CAGR of around 11.5% between 2021 and 2027. Brazil has developed a cancer prevention strategy and is recognized as one of the key countries to lower the rates of smoking in the coming years.

Based on end-use, the Brazil oncology market is segmented into public and private. The public segment is further segmented into hospitals, diagnostic laboratories, diagnostic imaging centers, academia, specialty clinics and others. The private segment is further segmented into hospitals, diagnostic laboratories, diagnostic imaging centers, academia, specialty clinics and others. The public segment is estimated to account for over 37% market proportion. The universal health coverage system in Brazil, also known as SUS, is the largest government-run public healthcare system in the world and offers different services free of cost to the admitted patients.

Brazil oncology market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:

Brazil Market, By Diagnostic & Treatment

  • Diagnostic
    • Tumor Biomarkers Test
    • Imaging
    • Biopsy
    • Liquid Biopsy
    • Immunohistochemistry
    • In Situ Hybridization
  • Treatment
    • Chemotherapy
    • Targeted therapy
    • Immunotherapy
    • Hormonal therapy
    • Others

Brazil Market, By Cancer Type

  • Lung cancer
  • Prostate cancer
  • Colon & rectal cancer
  • Gastric cancer
  • Esophageal cancer
  • Liver cancer
  • Breast cancer
  • Others

Brazil Market, By End-use

  • Public
    • Hospitals
    • Diagnostic laboratories
    • Diagnostic imaging centers
    • Academia
    • Specialty clinics
    • Others
  • Private
    • Hospitals
    • Diagnostic laboratories
    • Diagnostic imaging centers
    • Academia
    • Specialty clinics
    • Others

The above information has been provided for the following countries:

  • Brazil